JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 360 JPY 1.2%
Market Cap: ¥219.8B

P/FCFE

24.3
Current
35%
More Expensive
vs 3-y average of 18

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
24.3
=
Market Cap
¥265.6B
/
Free Cash Flow to Equity
¥9B

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
24.3
=
Market Cap
¥265.6B
/
Free Cash Flow to Equity
¥9B

Valuation Scenarios

JMDC Inc is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (18), the stock would be worth ¥2 486.58 (26% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-26%
Maximum Upside
+31%
Average Upside
4%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 24.3 ¥3 360
0%
3-Year Average 18 ¥2 486.58
-26%
5-Year Average 29.4 ¥4 060
+21%
Industry Average 31.8 ¥4 397.85
+31%
Country Average 22.4 ¥3 087.61
-8%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close
Market Cap P/FCFE P/E
JP
JMDC Inc
TSE:4483
219.8B JPY 24.3 26.7
JP
Medical Data Vision Co Ltd
TSE:3902
37.9T JPY 88.6 227.5
US
Cerner Corp
LSE:0R00
31.3B USD 36.2 53.1
US
Veeva Systems Inc
NYSE:VEEV
25.5B USD 18.4 28.1
AU
Pro Medicus Ltd
ASX:PME
14B AUD 119.5 60.7
JP
M3 Inc
TSE:2413
1T JPY 23.5 20.5
SE
Sectra AB
STO:SECT B
49.2B SEK 79.2 91.5
US
Waystar Holding Corp
NASDAQ:WAY
4.1B USD 8.8 35.7
US
Doximity Inc
NYSE:DOCS
4.5B USD 14.7 18.9
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
283.9B INR -201.6 42.8
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.1B CNY 80 -62.1

Market Distribution

In line with most companies in Japan
Percentile
54th
Based on 3 849 companies
54th percentile
24.3
Low
0.1 — 14.9
Typical Range
14.9 — 35
High
35 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 14.9
Median 22.4
70th Percentile 35
Max 736 044 589.7

JMDC Inc
Glance View

Market Cap
219.8B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 968.52 JPY
Undervaluation 15%
Intrinsic Value
Price ¥3 360
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett